Home » Newsletters » BioWorld Science

BioWorld Science

May 13, 2003

View Archived Issues

Promising findings announced for plague vaccine

Posttraumatic AMPA receptor antagonism results in neuroprotection in a rat head injury model

Structural changes in prostate DNA as a potential approach for predicting prostate cancer

Efficacy of a new diphenylchlorin sensitizer for PDT

Topical ciclosporin conjugate reported safe and effective in psoriasis

Topical 5-FU combined with celecoxib reduces UVB-induced skin tumors in mice

Spanish researchers synthesize novel synthetic glycoside with potent antitumor activity

FDA approves new flexible dosing regimen for Lantus

Guilford enters NAALADase licensing agreement with Pfizer

Adderall XR program in adolescents to extend marketing exclusivity

Progen updates development status of PI-88, PI-166

Licensing, INDs and acquisition at Inflazyme during the last quarter

Novel agents with utility in immune disorders identified at Kyorin

Kureha patent describes new CXCR4 antagonists for HIV infection, rheumatism and cancer

Nicotinic alpha7 agonists/partial agonists and their use covered by Mitsubishi patent

New MMP, TACE and/or aggrecanase inhibitors prepared by BMS researchers

New HER2 kinase inhibitors prepared and tested at Takeda

Lilly scientists identify phenanthrene-based LXR activators

5-HT1A antagonists with utility in urinary tract disorders under study at Recordati

Novel potassium channel activators discovered at Takeda

Synercid launched in Japan

BioTie enters VAP-1 licensing agreement with Seikagaku

ConjuChem initiates U.S. trial for DAC:GLP-1

Ligand, Lilly extend diabetes and cardiovascular drug discovery collaboration

Novartis acquires Enablex

Novartis acquires 51% of Idenix capital stock

Elidel approved in Canada for eczema

Antitumor and antimetastatic effects of a vitamin E analogue

Fab fragment targeting alpha5beta1 integrin inhibits CNV in monkeys

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...